Name: | Description: | Size: | Format: | |
---|---|---|---|---|
artigo principal | 2.18 MB | Adobe PDF |
Advisor(s)
Abstract(s)
Intravenous IgG (ivIg) is a therapeutic alternative for lupus erythematosus, the mechanism of which remains to be fully understood. Here we investigated whether ivIg affects two established sub-phenotypes of SLE, namely relative oligoclonality of circulating T-cells and reduced activity of CD4 + Foxp3+ regulatory T-cells (Tregs) reflected by lower CD25 surface density.
Description
Keywords
Adult Forkhead Transcription Factors Humans Interleukin-2 Receptor alpha Subunit Longitudinal Studies Lupus Erythematosus, Systemic Middle Aged Receptors, Antigen, T-Cell, alpha-beta T-Lymphocyte Subsets T-Lymphocytes, Regulatory Young Adult Immunoglobulins, Intravenous
Citation
Costa, N et al. J Clin Immunol (2013) 33: 349. doi:10.1007/s10875-012-9816-7